Viewing Study NCT03635632

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 9:40 PM
Ignite Modification Date: 2026-01-16 @ 10:47 AM
Study NCT ID: NCT03635632
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-07-25
First Post: 2018-08-13
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: C7R-GD2.CART Cells for Patients With Relapsed or Refractory Neuroblastoma and Other GD2 Positive Cancers (GAIL-N)
Sponsor: Baylor College of Medicine
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Relapsed Neuroblastoma View
None Refractory Neuroblastoma View
None Relapsed Osteosarcoma View
None Relapsed Ewing Sarcoma View
None Relapsed Rhabdomyosarcoma View
None Uveal Melanoma View
None Phyllodes Breast Tumor View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Gene Therapy View
None CAR T-cells View
None Neuroblastoma View
None chimeric antigen receptor View
None Immunotherapy View
None Sarcoma View
None Uveal Melanoma View
None Breast cancer View
None GD2 positive cancer View